InvestorsHub Logo
Followers 25
Posts 2345
Boards Moderated 0
Alias Born 06/20/2020

Re: jimmy667 post# 154757

Thursday, 03/25/2021 1:05:57 PM

Thursday, March 25, 2021 1:05:57 PM

Post# of 233144

Much of the financial risk is squeezed out by the low share price


CYDY doesn't have a low share price. Its market cap is $1.4 billion. That is outrageous for an incompetently run company with zero revenue and a drug that has failed. For comparison, HGEN has a market cap of $700 million and is run by scientific experts and has a drug that is likely to have amazing trial results because it attacks the cytokine GM-CSF which has been proven to be the cause of severe Covid and Covid death.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News